Back to search

Georgia Institute of Technology

Development of a novel In vitro blood brain barrier model for the evaluation of nanomedicines

Abstract

dc:description.abstract

In this work, we present a novel microfluidic lumen system of the BBB (MLS-BBB) for the evaluation of multifunctional nanomedicines engineered for the treatment of medulloblastoma. Our MLS-BBB is designed to co-culture human astrocytes (HA) and human brain vascular pericytes (HBVP) around a cylindrical lumen of human brain microvascular endothelial cells (HBMEC) within a 3D hydrogel system tuned to mimic the properties of brain extracellular matrix (ECM). Our MLS-BBB facilitates the administration of tunable shear rates to a lumen of endothelial cells in direct contact with supporting astrocyte and pericyte cells within a hydrogel system optimized to facilitate the appropriate culture of astrocytes, and is to our knowledge, the first model to do so. We employed high throughput qPCR techniques to simultaneously analyze expression of 85 BBB relevant endothelial specializations such as junctional proteins (ZO-1, Claudins, JAMs, etc.), specialized transporters (GLUT-1, CAT1, TfR, etc.) and drug resistant proteins (PgP, ABCC1, ABCC4, etc.). Our results indicate that our system provides a marked increase in physiological relevance relative to transwell culture systems. Our model was further validated through comparison to BBB spheroids, by examination of model response to perturbations of the optimized ECM composition, and examination of response to the administration of TNFα, an inflammatory cytokine. Our model is currently being employed in parallel with traditional transwell systems and ex vivo brain slice cultures in the preliminary evaluation of a novel nanomedicine designed for the treatment of sonic hedgehog driven (SSH) medulloblastoma to evaluate its functional utility in such studies. The ultimate goal of organ-on-a-chip model development is eventual adaptation by the community for preclinical assessment of novel drug compounds. While our MLS-BBB could be improved in several ways, including modification to a high throughout design, by combining comprehensive characterization with an assessment of functional utility relative to standard in vitro controls, we believe our work constitutes a significant step towards the realization of this goal.

Degree

thesis:*
Level thesis:degree_level
Doctoral
Department dc:contributor.department
Biomedical Engineering (Joint GT/Emory Department)
Grantor dc:publisher
Georgia Institute of Technology
Year dc:date.issued
2017

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Hovell, Candice Megan
Advisors dc:contributor.advisor
  • Taite, Lakeshia J.
  • Kim, YongTae
  • Barabino, Gilda
Committee members dc:contributor.committeemember
  • Lu, Hang
  • Botchwey, Edward A.
  • Dixon, J. Brandon
  • Vazquez, Maribel

Subjects

dc:subject × 2

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1853/60667

Chain of custody

source
Harvested from
Georgia Tech
Base URL
repository.gatech.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Hovell, Candice Megan. Development of a novel In vitro blood brain barrier model for the evaluation of nanomedicines. Doctoral thesis, Georgia Institute of Technology, 2017. http://hdl.handle.net/1853/60667